Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The Leukemia & Lymphoma Society’s Dare to Dream project helps pediatric cancer patients like Cayden, who received CAR-T therapy.
“I envision LLS continuing to be a leading innovator, driving change that impacts all cancer care,” says E. Anders Kolb, MD.
That’s a new blood cancer diagnosis approximately every three minutes.
The drug shortage has impacted 93% of surveyed cancer centers, according to the National Comprehensive Cancer Network.
The FDA approved Vanflyta (quizartinib) with chemotherapy for FLT3-mutated AML, an aggressive type of blood cancer.
Preclinical findings highlight bacterial groups that influence the risk for graft-versus-host-disease in blood cancer transplant patients.
The days of Americans paying far more for prescription drugs are ending, said President Biden.
These individuals work to ensure fair opportunities to prevent, treat and survive cancer.
Meet the latest grant recipients of The Leukemia & Lymphoma Society’s Equity in Access Research Program.
A three-drug regimen helps protect against GVHD after stem cell transplant for those with leukemia, lymphoma and similar cancers.
New research by Dana-Farber scientists looks at elevated body mass index and chemotherapy for acute lymphoblastic leukemia (ALL).
Trial showed that treatment with quizartinib led to a significant improvement in overall survival.
An influential author and out lesbian, Susan Love advanced innovative ideas on breast cancer as well as hormone replacement therapy.
Loui J. DeGennaro, PhD, served 18 years at LLS, a nonprofit funder of blood cancer research and clinical trials.
Lawmakers were asked to support the NIH Clinical Trials Diversity Act and kids’ access to cancer care.
When Charlie Huang almost lost the chance at a lifesaving stem cell transplant for his acute myeloid leukemia, he vowed to help others.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.